40 mg/day vormatrogine for 12 weeks

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresNCT07505004Praxis Precision MedicinesPhase 3Active not recruiting2027-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.